PROFITELLIGENCE/Guest access
!
Financial disclaimer

Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.

Legal agreement

By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.

i
Guest mode

You're browsing as a guest. Some features like watchlists and alerts require a free account.

--:--:--
Guest mode— viewing MCK. Sign up free to access all symbols.Sign up
MCK logo

MCK

McKesson Corporation

HealthcareMedical Distribution

Price performance

Sep 18, 2026
$874.65
$4.92-0.56%
1M
+2.45%
3M
+16.52%
YTD
+6.22%
vs SPY
+4.40%
30d range
838–930
Volatility
27.61%
Signals
Price chart

Company activity

31 events
Company activity
TimeTickerTypeEventQtyPriceValue
08/28MCK8-KMcKesson Discloses Cybersecurity Incident
08/05MCK8-KMcKesson Raises Full-Year Adjusted EPS Guidance
07/24MCK8-KMcKesson Corporation Announces Annual Meeting Results
07/01MCK8-KMcKesson Appoints New Chief Strategy Officer
06/12MCK8-KMcKesson Corporation Enters into $2.25 Billion Term Loan Facility
05/07MCK8-KMcKesson Reports Strong Fiscal 2026 Results and Announces Share Repurchase Program
04/28MCK8-KMcKesson Enters New $5 Billion Revolving Credit Facility
04/06MCK8-KMcKesson Corporation Subsidiaries Enter into $2 Billion Credit Agreement
03/06MCK8-KMcKesson Announces Q4 Fiscal 2026 Earnings Release Date and Conference Participation
03/05MCK8-KMcKesson Appoints New CFO Following Retirement of Britt J. Vitalone
02/04MCK8-KMcKesson Reports Q3 Earnings Beat and Raises FY Guidance
11/05/25MCK8-KMcKesson Corporation Reports Strong Q2 2026 Results and Raises Full Year Guidance
09/23/25MCK8-KMcKesson Updates Fiscal 2026 Guidance and Long-Term Targets at Investor Day
09/18/25MCK8-KMcKesson Reorganizes into Four Reportable Segments
08/06/25MCK8-KMcKesson Reports Q1 FY26 Results: Revenue Up 23%, Adjusted EPS Up 5%, Raises Guidance
08/01/25MCK8-KMcKesson Corporation Shareholders Approve Director Elections and Executive Compensation
06/09/25MCK8-KMcKesson Adjusts Fiscal Year 2026 Financial Outlook
05/30/25MCK8-KMcKesson Corporation Announces Closing of $2 Billion Notes Offering
05/08/25MCK8-KMcKesson Reports Strong Fiscal 2025 Performance and Provides Fiscal 2026 Guidance
02/05/25MCK8-KMcKesson Reports Q3 FY25 Results and Raises Full-Year Guidance
02/05/25MCK8-KMcKesson Reports Strong Q3 Results and Raises FY25 Guidance
11/06/24MCK8-KMcKesson Reports Fiscal Q2 2025 Results and Raises Full Year Guidance
09/10/24MCK8-KMcKesson Corporation Announces New Notes Offering and Redemption of 2026 Notes
09/05/24MCK8-KMcKesson Announces Fiscal 2025 Earnings Guidance
08/26/24MCK8-KMcKesson Announces Acquisition of Core Ventures
08/07/24MCK8-KMcKesson Announces First Quarter 2025 Results and Raises Fiscal 2025 Guidance
08/02/24MCK8-KMcKesson Corporation Annual Shareholders' Meeting Results
06/03/24MCK8-KMcKesson Appoints Deborah Dunsire as New Director
05/07/24MCK8-KMcKesson Reports Preliminary Q4 and FY 2024 Results
02/07/24MCK8-KMcKesson Reports Q3 2024 Results and Raises Full-Year Guidance
01/09/24MCK8-KMcKesson Elects New Director and Announces Acquisition

MCK filing record

McKesson Corporation (MCK): 31 8-K filings summarized, the most recent on Aug 28, 2026.

What the 8-K filings said

  1. Aug 28, 2026 · high impact

    On August 25, 2026, McKesson Corporation disclosed a cybersecurity incident affecting its information systems. The company is in the early stages of investigating the incident and has not yet determined if it is material or if it will have any material impact on its financial condition or results of operations.…

    McKesson Discloses Cybersecurity Incident
  2. Aug 5, 2026 · high impact

    McKesson Corporation reported a preliminary increase in adjusted earnings per diluted share for the first quarter of fiscal 2027, leading to an increase in the full-year adjusted earnings per diluted share guidance. The company's consolidated revenues for the quarter were $105.4 billion, an 8% increase from the prior…

    McKesson Raises Full-Year Adjusted EPS Guidance
  3. Jul 24, 2026 · medium impact

    On July 22, 2026, McKesson Corporation held its Annual Meeting of Shareholders, where all nominated directors were elected, the appointment of Deloitte & Touche LLP as the independent registered public accounting firm was ratified, and the advisory vote on executive compensation was approved. These outcomes reflect…

    McKesson Corporation Announces Annual Meeting Results
  4. Jul 1, 2026 · high impact

    On June 29, 2026, McKesson Corporation announced the retirement of Thomas L. Rodgers, Executive Vice President and Chief Strategy and Business Development Officer, effective August 1, 2026. To ensure a smooth transition, Ramesh Srinivasan has been appointed as the new Executive Vice President and Chief Strategy…

    McKesson Appoints New Chief Strategy Officer
  5. Jun 12, 2026 · medium impact

    On June 9, 2026, McKesson Corporation's subsidiary, McKesson Medical-Surgical Top Holdings, Inc., entered into an amendment to its Credit Agreement to establish a $2.25 billion senior secured term 'B' loan facility due 2032. The loan will bear interest at a rate equal to either the Adjusted Term SOFR Rate plus 2.25%…

    McKesson Corporation Enters into $2.25 Billion Term Loan Facility

SEC filings in the last five years

  • 48 Form 8-K
  • 14 Form 10-Q
  • 4 Form 10-K
  • 1 Form 8-K/A